Literature DB >> 11947926

Reduced levels of gamma-interferon secretion in response to chlamydial 60 kDa heat shock protein amongst women with pelvic inflammatory disease and a history of repeated Chlamydia trachomatis infections.

J Debattista1, P Timms, J Allan, J Allan.   

Abstract

Peripheral lymphocytes in uninfected fertile controls, women with various histories of Chlamydia trachomatis infection, pelvic inflammatory disease (PID) and infertility not due to C. trachomatis infection (endometriosis) were cultured overnight with PHA mitogen and the 60 kDa chlamydial heat shock protein. Plasma samples were then assayed for levels of gamma-interferon and IL-10 using a commercial ELISA system. Women with PID and those with a history of multiple C. trachomatis infections showed reduced gamma-interferon production in response to cHSP60, not seen in women infected only once and those with infertility due to other causes (endometriosis). Secretion of IL-10 in response to cHSP60 did not vary significantly across the various patient groups, though all patients showed elevated levels of total IL-10 compared with uninfected controls.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11947926     DOI: 10.1016/s0165-2478(02)00036-6

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  16 in total

Review 1.  Human and Pathogen Factors Associated with Chlamydia trachomatis-Related Infertility in Women.

Authors:  S Menon; P Timms; J A Allan; K Alexander; L Rombauts; P Horner; M Keltz; J Hocking; W M Huston
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

Review 2.  Pathogenesis of genital tract disease due to Chlamydia trachomatis.

Authors:  Toni Darville; Thomas J Hiltke
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

Review 3.  Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies.

Authors:  Byron E Batteiger; Fujie Xu; Robert E Johnson; Michael L Rekart
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

4.  Tuberculosis and the risk of infection with other intracellular bacteria: a population-based study.

Authors:  M A Huaman; C T Fiske; T F Jones; J Warkentin; B E Shepherd; L A Ingram; F Maruri; T R Sterling
Journal:  Epidemiol Infect       Date:  2014-08-22       Impact factor: 2.451

Review 5.  Tissue-Resident T Cells as the Central Paradigm of Chlamydia Immunity.

Authors:  Raymond M Johnson; Robert C Brunham
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

6.  Serovar-specific immune responses to peptides of variable regions of Chlamydia trachomatis major outer membrane protein in serovar D-infected women.

Authors:  Pragya Srivastava; Rishein Gupta; Hem Chandra Jha; Rajneesh Jha; Apurb Rashmi Bhengraj; Sudha Salhan; Aruna Mittal
Journal:  Clin Exp Med       Date:  2008-09-25       Impact factor: 3.984

7.  An atypical CD8 T-cell response to Chlamydia muridarum genital tract infections includes T cells that produce interleukin-13.

Authors:  Raymond M Johnson; Micah S Kerr; James E Slaven
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

8.  CD4+ T cell expression of MyD88 is essential for normal resolution of Chlamydia muridarum genital tract infection.

Authors:  Lauren C Frazer; Jeanne E Sullivan; Matthew A Zurenski; Margaret Mintus; Tammy E Tomasak; Daniel Prantner; Uma M Nagarajan; Toni Darville
Journal:  J Immunol       Date:  2013-09-13       Impact factor: 5.422

9.  Preliminary characterisation of tumor necrosis factor alpha and interleukin-10 responses to Chlamydia pecorum infection in the koala (Phascolarctos cinereus).

Authors:  Marina Mathew; Kenneth W Beagley; Peter Timms; Adam Polkinghorne
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

10.  Unveiling New Molecular Factors Useful for Detection of Pelvic Inflammatory Disease due to Chlamydia trachomatis Infection.

Authors:  Carmen Rodriguez-Cerdeira; Elena Sanchez-Blanco; Alberto Molares-Vila; Alfonso Alba
Journal:  ISRN Obstet Gynecol       Date:  2012-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.